Shandong Jincheng Pharmaceutical Group Co., Ltd (SHE:300233)
China flag China · Delayed Price · Currency is CNY
15.94
-0.16 (-0.99%)
May 8, 2026, 10:05 AM CST

SHE:300233 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
776.24826.03917.911,025859.13981.18
Trading Asset Securities
18070----
Cash & Short-Term Investments
956.24896.03917.911,025859.13981.18
Cash Growth
12.01%-2.38%-10.42%19.27%-12.44%-8.75%
Accounts Receivable
733.65691.8696.8794.56803.39684
Other Receivables
3.683.236.297.814.625.08
Receivables
737.33695.03703.09802.37808.01689.08
Inventory
446.54464.61598.86501.28579.22391.32
Prepaid Expenses
---0.20.550.01
Other Current Assets
34.6530.1638.4240.7761.2477.68
Total Current Assets
2,1752,0862,2582,3692,3082,139
Property, Plant & Equipment
2,0952,1482,3102,4682,4692,093
Long-Term Investments
181.77181.84183.28147.52141.22143.31
Other Intangible Assets
542.98545.61513.51547.29452.2449.75
Long-Term Deferred Tax Assets
41.8747.663.9469.7751.9630.71
Long-Term Deferred Charges
140.88147.98252.96310.89369.59329.72
Other Long-Term Assets
34.0433.9323.53.5134.4289.77
Total Assets
5,2115,1915,6055,9165,8265,275
Accounts Payable
469.58498.19552.56824726.05515.31
Accrued Expenses
157.69295.44355.9402.32394.98362.19
Short-Term Debt
70.05120.0855.0494212.89223
Current Portion of Long-Term Debt
244.79168.67101.52109.24163.2155.45
Current Portion of Leases
-1.770.130.721.112.37
Current Income Taxes Payable
41.512.4121.5324.8518.8418.72
Current Unearned Revenue
107.5140.7850.9432.7444.6754.47
Other Current Liabilities
16484.7693.35112.47139.284.94
Total Current Liabilities
1,2551,2221,2311,6001,7011,416
Long-Term Debt
17.4885.52351.99346.7271.69208.29
Long-Term Leases
4.063.46.883.462.0263.52
Long-Term Unearned Revenue
43.1945.2453.8861.66654.81
Long-Term Deferred Tax Liabilities
106.8110.68129.1122.94126.2192.66
Total Liabilities
1,4271,4671,7732,1352,1671,836
Common Stock
383.87383.87383.87383.87387.41387.41
Additional Paid-In Capital
2,330--2,3282,3972,404
Retained Earnings
1,001943.381,051967.95850.41653.34
Treasury Stock
-55.01-55.01-55.01--56.94-80.01
Comprehensive Income & Other
62.12,3912,38734.6229.3329.44
Total Common Equity
3,7233,6633,7673,7143,6073,394
Minority Interest
61.860.5865.1766.9351.8744.96
Shareholders' Equity
3,7843,7243,8323,7813,6593,439
Total Liabilities & Equity
5,2115,1915,6055,9165,8265,275
Total Debt
336.38379.44515.56554.12650.91652.62
Net Cash (Debt)
619.86516.59402.35470.54208.22328.55
Net Cash Growth
80.56%28.39%-14.49%125.98%-36.62%-50.66%
Net Cash Per Share
1.691.401.061.210.540.85
Filing Date Shares Outstanding
385.3379.33379.33383.87383.1383.87
Total Common Shares Outstanding
385.3379.33379.33383.87383.1383.87
Working Capital
919.64863.751,027768.95607.21722.83
Book Value Per Share
9.669.669.939.689.428.84
Tangible Book Value
3,1803,1183,2533,1673,1552,945
Tangible Book Value Per Share
8.258.228.588.258.247.67
Buildings
-1,5391,4241,4061,3561,021
Machinery
-2,4412,4142,2892,1521,671
Construction In Progress
-3.3673.33148.97121.31332.32
Source: S&P Global Market Intelligence. Standard template. Financial Sources.